Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Celebrity Make-Up Artist Highlights Plight of Rosacea Sufferers


News provided by

Galderma

02 Aug, 2016, 07:00 GMT

Share this article

Share toX

Share this article

Share toX

This image opens in the lightbox
Experience My Rosacea campaign spokesperson and celebrity make-up artist Sarah Jagger (PRNewsFoto/Galderma)

LONDON, August 2, 2016 /PRNewswire/ --

A day in the life experience that proves rosacea is more than skin deep 

Alone and red faced - looking beyond the cosmetic issue of rosacea  

A beautiful woman walks down the busy streets of Covent Garden, London and heads turn. She walks into a bar and orders a glass of wine; people look on and whispers murmur. 

For genetically gifted Sarah Jagger, you'd think she was used to people staring. Yet she feels self-conscious today. Her first thoughts are that people are negatively judging her, 'that it is my skin they're staring at'. 

For approximately 10% of the UK population,[1] this can be an everyday reality caused by the skin condition rosacea.

Celebrity make-up artist, Sarah Jagger, braved public reactions to the very visual symptoms of a rosacea flare-up to highlight the impact this common skin condition has on sufferers' mental health and wellbeing.

     (Photo: http://photos.prnewswire.com/prnh/20160801/394428 )

To address the current lack of rosacea awareness, Sarah, herself a rosacea sufferer, used her make-up expertise to show the visible symptoms of a rosacea flare up. Together with Embarrassing Bodies' Dr Dawn Harper and Dr Anton Alexandroff, Consultant Dermatologist at University Hospitals Leicester, she took to the streets of London to see the public's reaction and experience first-hand current perceptions and misconceptions towards the condition. This was part of the 'Experience My Rosacea' disease awareness campaign.

"It was a truly insightful experience," commented Sarah, "I spend my time helping people cover up their imperfections and help them feel confident in their skin. However, during this experience I felt increasingly conscious of those around me, constantly wondering what they were thinking. It was completely isolating."

Rosacea is a relapsing, multi-symptom, long-term skin condition, characterised by facial redness and flushing, caused by abnormal blood flow to the top layers of the skin.[2] Other symptoms which can occur are bumps and pimples (papules and pustules) and, in severe cases, facial disfiguration, if left unmanaged.[2] Yet despite rosacea affecting approximately 10% of the UK population,[1] sufferers continue to suffer in silence - with individuals often being emotionally affected by both their appearance and associated social stigmas.

A nationwide survey comparing male and female faces with and without the visible symptoms of rosacea showed just how pervasive the influence of rosacea can be, with people admitting to be less likely to believe that a person with facial redness is married or dating, and less likely to believe they are intelligent, trustworthy or reliable.[3]

Of her own experience with rosacea Sarah commented: "I have suffered from rosacea for a long time and especially when I was much younger, it was not just the physical symptoms that affected me; it had a real impact on my self-esteem. Through my involvement in this campaign, I want those with the condition to realise that they are not alone and that there are people and resources out there that can help."

On the day, members of the public interviewed had limited awareness of rosacea. Of those who knew what it was, many held incorrect perceptions about it, including that the red facial flushing associated with the condition was caused by drinking alcohol. Despite being so common, a recent survey revealed that nearly one-third of people are unaware of what it is,[4] and it remains misunderstood, and often misjudged.

For sufferers, the impact of rosacea can be complex and far reaching. Due to its visible nature, and the fact that it affects the face, it often affects self-esteem and consequently, anxiety and depression are common among sufferers.[5],[6]

Dr Dawn Harper said: "I've heard from patients how having rosacea affects them day-to-day, but this is the first time I have seen the sort of reactions that people with rosacea can face. I'm pleased to be involved in this campaign as I think it is important for rosacea sufferers to seek a diagnosis for this condition and know there is help available."

Sufferers often go for extended periods of time before seeking a correct diagnosis and treatment; often relying on cosmetic products to cover up the symptoms rather than addressing them. Rosacea's exact cause is unknown but chronic inflammation is believed to play a key role. Certain triggers: heat, cold, intense physical exercise, alcohol and caffeine, can intensify it.[1],[5] Until recently, rosacea management was frequently limited to dietary and lifestyle adjustments such as avoiding key triggers.[1]

Dr Anton Alexandroff, Consultant Dermatologist at University Hospitals Leicester, said: "Rosacea is often misunderstood and until now we have been extremely limited in the options we can offer people suffering from facial redness. Some patients are prescribed anti-inflammatory antibiotics - which treat the pimples and pustules associated with rosacea but fail to combat facial redness and flushing. But different treatment options are becoming available - so people suffering need to speak to their healthcare professional. Typically the symptoms associated with rosacea get worse if left untreated so it's key that we recognise and treat this condition."

To further raise awareness of rosacea and to create an online community for rosacea sufferers, the 'Experience My Rosacea' microsite has been created: http://www.experiencemyrosacea.co.uk. Here, those with rosacea, or an interest on the subject, can share stories and advice from their own blogs. These include posts on personal experiences with rosacea, as well as general skincare/beauty tips.

To find out more about rosacea and the Experience My Rosacea campaign, please visit http://www.experiencemyrosacea.co.uk.

For further information about the company, please visit: http://www.galderma.co.uk

Galderma - a global company exclusively dedicated to dermatology

Galderma is a global company founded in 1981 committed to delivering innovative medical solutions to meet the dermatological needs of people throughout their lifetime while serving healthcare professionals around the world. The company has 33 wholly-owned affiliates with a worldwide network of distributors and more than 5,000 employees. Galderma's extensive product portfolio is available in 80 countries and treats a range of dermatological conditions including: acne, rosacea, onychomycosis, psoriasis & steroid-responsive dermatoses, pigmentary disorders, skin cancer and medical solutions for skin senescence.

With approximately 19% of revenues invested each year to discover and develop new products and access innovative technologies, the company is one of the world's leading investors in dermatology R&D. Five state-of-the-art R&D centers and five manufacturing sites are dedicated to providing a wide range of innovative medical solutions which meet the highest standards of safety and efficacy.

Strategic brands include Epiduo, Efracea, Etrivex, Differin, Mirvaso®, Rozex/MetroGel, Silkis, Loceryl/Curanail, Cetaphil, Metvix, Azzalure, Restylane and Emervel.

References:
1. NHS Choices. Rosacea Introduction. http://www.nhs.uk/conditions/Rosacea/Pages/Introduction.aspx. Accessed May 2015.
2. Powell FC. Rosacea. N Engl J Med. 2005;352:793-80.
3. Face Values: Global Perceptions Survey (UK data). January 2014.
4. National Rosacea Society. Surveys Show Need for More Education. http://www.rosacea.org/rr/2009/summer/article_4.php. Last accessed April 2016.
5. Blount BW, Pelletier AL. Rosacea: a common, yet commonly overlooked, condition. Am Fam Physician. 2002;66:435-440.
6. Chodkiewicz J, Salamon M, Miniszewska J, Woźniacka A. Psychosocial impact of rosacea. PubMed. 2007; 64(12):997-1001. http://www.ncbi.nlm.nih.gov/pubmed/18595501. Accessed May 2016.

Galderma (UK) Ltd
Ruth Baxter
Group Product Manager
Tel: +44(0)1923-208950
E-mail: ruth.baxter@galderma.com

Ruder Finn
Sarah Moodie
Account Manager
Tel: +44(0)-20-7438-3074
E-mail: smoodie@ruderfinn.co.uk


Date of preparation: May 2016
Jobcode: GEN/339/1115t

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.